Actuate 1901: 9-ING-41 in Myelofibrosis
Study sponsor: Actuate Therapeutics Inc. · ACTU
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-10-13Actual
Enrollment · participants17Actual
Source updated2024-02-07Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.